|
Posted by Vincent on February 8, 2010, 10:01 am
Athersys, Inc., is a biopharmaceutical company engaged in the discovery
and development of therapeutic products. Through the application of its
technologies, the Company has established a pipeline of therapeutic
product development programs in multiple disease areas. The Company's
current product development portfolio consists of MultiStem, a patented
and stem cell product that the Company is developing as a treatment for
multiple disease indications, and that is being evaluated in two ongoing
clinical trials. In addition, the Company are developing novel
pharmaceuticals to treat indications such as obesity, certain cognitive
and attention disorders, narcolepsy or other forms of excessive daytime
sleepiness. In December 2008, the Company were granted authorization by
the United States Food and Drug Administration (FDA), to initiate a
third clinical trial, administering MultiStem for the treatment of
ischemic stroke.
|